Propylthiouracil-induced alveolar hemorrhage

Area of Science:

• Internal Medicine
• Rheumatology
• Endocrinology

Background:

• Thionamide medications, used for conditions like Graves' disease, can trigger vasculitis, a multisystem inflammatory disorder.
• Patients often test positive for perinuclear antineutrophil cytoplasmic antibodies (pANCA) or antimyeloperoxidase (MPO), though not all ANCA-positive patients on thionamides develop symptoms.
• While discontinuing the drug often resolves symptoms, some cases necessitate aggressive treatments like high-dose steroids, immunosuppressants, or plasmapheresis.

Purpose of the Study:

• To report a rare case of alveolar hemorrhage caused by propulthiouracil (PTU).
• To illustrate the management and successful recovery of a patient with PTU-induced vasculitis affecting the lungs.

Main Methods:

• A case study of a patient treated for Graves' disease with PTU who developed alveolar hemorrhage.
• Treatment involved a combination of corticosteroid therapy, cyclophosphamide, and plasmapheresis.

Main Results:

• The patient presented with alveolar hemorrhage, a severe manifestation of thionamide-induced vasculitis.
• Complete recovery was achieved through the combined therapeutic approach.

Conclusions:

• Propulthiouracil can induce vasculitis presenting as alveolar hemorrhage.
• Aggressive treatment including corticosteroids, cyclophosphamide, and plasmapheresis can lead to complete recovery in severe cases of PTU-induced vasculitis.